On the 14 February the Woolcock Institute of Medical Research (WIMR) hosted a party to celebrate the opening of the new state-of-the-art laboratory facilities. The new suite of labs will allow researchers to focus on developing new technology and approaches for treating respiratory diseases.
Diseases such as asthma, COPD, pulmonary infection and lung cancer affect hundreds of thousands of people worldwide. The new laboratories will allow the WIMR to bridge basic sciences with the clinic to develop new drug delivery systems for treating these diseases. The new laboratory facilities include a 3D prototyping centre, thermal analysis suite, particle sizing room, imaging lab, analytical chemistry hub and particle engineering and aerosol characterisation labs. The Respiratory Technology group will utilise these facilities to identify and target diseases, engineer new devices, formulate drug delivery system and test formulation effectiveness in vitro.
The laboratories were opened by Robert Estcourt (Chairman of the Board), and Carol Armour (Director of the Institute) and the celebrations attended by Institute Members, Collaborators, Industry Supporters and Friends of the WIMR.